Stockreport

Eupraxia Pharmaceuticals expands trial of eosinophilic esophagitis therapy [Yahoo! Finance]

Eupraxia Pharmaceuticals Inc.  (EPRX) 
PDF The expansion follows promising initial data and aims to explore higher doses and longer follow-up periods in additional trial subjects. The dose-escalation, multi-ce [Read more]